AMICUS THERAPEUTICS INC's ticker is FOLD and the CUSIP is 03152W109. A total of 149 filers reported holding AMICUS THERAPEUTICS INC in Q3 2015. The put-call ratio across all filers is 0.49 and the average weighting 0.5%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2017 | $399,000 | +31.2% | 55,900 | -8.6% | 0.01% | +100.0% |
| Q4 2016 | $304,000 | -4.1% | 61,149 | +42.9% | 0.01% | 0.0% |
| Q3 2016 | $317,000 | -67.2% | 42,783 | -62.6% | 0.01% | -58.8% |
| Q1 2016 | $967,000 | +111.6% | 114,400 | +142.9% | 0.02% | +240.0% |
| Q4 2015 | $457,000 | -44.3% | 47,100 | -19.6% | 0.01% | -28.6% |
| Q3 2015 | $820,000 | -6.0% | 58,579 | -4.9% | 0.01% | -12.5% |
| Q2 2015 | $872,000 | +134.4% | 61,600 | +80.7% | 0.01% | +100.0% |
| Q1 2015 | $372,000 | +135.4% | 34,098 | +79.8% | 0.00% | +300.0% |
| Q4 2014 | $158,000 | -55.7% | 18,968 | -68.4% | 0.00% | 0.0% |
| Q3 2014 | $357,000 | – | 59,960 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Palo Alto Investors LP | 10,524,022 | $127,972,108 | 12.11% |
| Perceptive Advisors | 27,692,917 | $336,745,870 | 11.23% |
| Redmile Group, LLC | 16,944,621 | $206,046,591 | 9.80% |
| Finepoint Capital LP | 1,489,025 | $18,106,544 | 9.02% |
| CM Management, LLC | 450,000 | $5,472,000 | 5.81% |
| Avoro Capital Advisors LLC | 27,400,000 | $333,184,000 | 5.20% |
| MPM BioImpact LLC | 716,139 | $8,708,250 | 2.32% |
| Artal Group S.A. | 4,062,567 | $49,401 | 2.12% |
| SECTORAL ASSET MANAGEMENT INC | 803,464 | $9,770,122 | 1.90% |
| GREAT POINT PARTNERS LLC | 857,000 | $10,421,120 | 1.90% |